The concept of in vivo airway tissue engineering

Biomaterials

Volumn 33, Issue 17, 2012, Pages 4319-4326

  Jungebluth, Philipp ^a,e   Bader, Augustinus ^b   Baiguera, Silvia ^c   Möller, Susanne ^a   Jaus, Massimo ^c   Lim, Mei Ling ^a   Fried, Kaj ^a   Kjartansdóttir, Kristín Rós ^a   Go, Tetsuhiko ^c   Nave, Heike ^d   Harringer, Wolfgang ^e   Lundin, Vanessa ^a   Teixeira, Ana I ^a   Macchiarini, Paolo ^a,c,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c European Center of Thoracic Research (CERT)   (Italy)

^d MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^e KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

Boosting therapy; Decellularized trachea; In vivo tissue engineering; Intraoperative seeding

Indexed keywords

BENEFICIAL EFFECTS; BIOACTIVE MOLECULES; BOOSTING THERAPY; CELL TYPES; DECELLULARIZED; ENGRAFTMENT; GROWTH FACTOR; IN VIVO TISSUE ENGINEERING; IN-SITU; IN-VITRO; IN-VIVO; INTRA-OPERATIVE; MONONUCLEAR CELLS; REGENERATIVE PROCESS; UP-REGULATION;

BIOACTIVITY; BIOREACTORS; GENES; RESPIRATORY SYSTEM; STEM CELLS; TISSUE;

SCAFFOLDS (BIOLOGY);

TISSUE SCAFFOLD;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOREACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL PIG; IN VIVO STUDY; INTRAOPERATIVE PERIOD; MONONUCLEAR CELL; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REGENERATION; RESPIRATORY EPITHELIUM; STEM CELL; TISSUE ENGINEERING; TRACHEA; UPREGULATION;

ANIMALS; BIOMECHANICS; CELL SEPARATION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MESENCHYMAL STEM CELLS; RNA, MESSENGER; SUS SCROFA; TISSUE ENGINEERING; TRACHEA;

SUIDAE;

EID: 84858860614     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.03.016     Document Type: Article

References (28)

1. Grillo H.C. Tracheal replacement: a critical review. Ann Thorac Surg 2002, 73:1995-2004.
2. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E., Cogan T.A., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372:2023-2030.
3. Go T., Jungebluth P., Baiguero S., Asnaghi A., Martorell J., Ostertag H., et al. Both epithelial cells and mesenchymal stem cell-derived chondrocytes contribute to the survival of tissue-engineered airway transplants in pigs. J Thorac Cardiovasc Surg 2010, 139:437-443.
4. Asnaghi M.A., Jungebluth P., Raimondi M.T., Dickinson S.C., Rees L.E., Go T., et al. A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial. Biomaterials 2009, 30:5260-5269.
5. Jungebluth P., Go T., Asnaghi A., Bellini S., Martorell J., Calore C., et al. Structural and morphologic evaluation of a novel detergent-enzymatic tissue-engineered tracheal tubular matrix. J Thorac Cardiovasc Surg 2009, 138:586-593. discussion 92-3.
6. Baiguera S., Jungebluth P., Burns A., Mavilia C., Haag J., De Coppi P., et al. Tissue engineered human tracheas for in vivo implantation. Biomaterials 2010, 31:8931-8938.
7. Macchiarini P., Walles T., Biancosino C., Mertsching H. First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg 2004, 128:638-641.
8. Macchiarini P., Lenot B., de Montpreville V., Dulmet E., Mazmanian G.M., Fattal M., et al. Heterotopic pig model for direct revascularization and venous drainage of tracheal allografts. J Thorac Cardiovasc Surg 1994, 108:1066-1075. Paris-Sud University Lung Transplantation Group.
9. Curcio E., Macchiarini P., De Bartolo L. Oxygen mass transfer in a human tissue-engineered trachea. Biomaterials 2010, 31:5131-5136.
10. Eudra CT Nr. 2006-002886-38. Erythropoietin in burn treatment - A multicenter clinical trial. and . http://chirnet.clinicalsite.org/de/trial/376.
11. Bader A., Macchiarini P. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J Cell Mol Med 2010, 14:1877-1889.
12. Delgaudine M., Lambermont B., Lancellotti P., Roelants V., Walrand S., Vanoverschelde J.L., et al. Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice. Cytotherapy 2011, 13:237-247.
13. Jungebluth P., Alici E., Baiguera S., Le Blanc K., Blomberg P., Bozoky B., et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 2011, 378:1997-2004.
14. Bader A., Lorenz K., Richter A., Scheffler K., Kern L., Ebert S., et al. Interactive role of trauma cytokines and erythropoietin and their therapeutic potential for acute and chronic wounds. Rejuvenation Res 2011, 14:57-66.
15. Brines M., Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 2008, 264:405-432.
16. Le Blanc K., Samuelsson H., Lonnies L., Sundin M., Ringden O. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation 2007, 84:1055-1059.
17. Urbani S., Caporale R., Lombardini L., Bosi A., Saccardi R. Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells. Cytotherapy 2006, 8:243-253.
18. Castro-Malaspina H., Gay R.E., Resnick G., Kapoor N., Meyers P., Chiarieri D., et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980, 56:289-301.
19. Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976, 4:267-274.
20. Ribatti D., Guidolin D., Conconi M.T., Nico B., Baiguera S., Parnigotto P.P., et al. Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene 2003, 22:6458-6461.
21. Baiguera S., Conconi M.T., Guidolin D., Mazzocchi G., Malendowicz L.K., Parnigotto P.P., et al. Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int J Mol Med 2004, 14:849-854.
22. Baiguera S., Birchall M.A., Macchiarini P. Tissue-engineered tracheal transplantation. Transplantation 2010, 89:485-491.
23. Furlani D., Li W., Pittermann E., Klopsch C., Wang L., Knopp A., et al. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant 2009, 18:319-331.
24. Ikada Y. Challenges in tissue engineering. J R Soc Interface 2006, 3:589-601.
25. Grillo H.C. Tracheal replacement. J Thorac Cardiovasc Surg 2003, 125:975.
26. Santacruz J.F., Mehta A.C. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009, 6:79-93.
27. Bader A., Machens H.G. Recombinant human erythropoietin plays a pivotal role as a topical stem cell activator to reverse effects of damage to the skin in aging and trauma. Rejuvenation Res 2010, 13:499-500.
28. Jungebluth P., Moll G., Baiguera S., Macchiarini P. Tissue-engineered airway: a regenerative solution. Clin Pharmacol Ther 2012, 91:81-93.